Betty and all,
>From what we hear, the money issue is on both sides of the
question: how much will it cost to R+D a new drug and then
HOW MUCH CAN THE DRUG COMPANY EXPECT TO MAKE BACK. If the
second question has an unsatisfactory answer, then the first
becomes moot.
Mike
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
